Succinct, simply worded standard operating procedures (SOPs) that can be expressed in cartoon or flowchart format lead to higher rates of compliance, pharma experts say.

Inadequate process implementation is the top reason why drugmakers get slapped with warning letters, so it’s important that SOPs are task-specific and easy for a user to understand, Mukesh Kumar, a senior director at contract research group Amarex Clinical Research, said.

Companies should ask themselves if their SOPs are simple enough to make into a cartoon, Kumar said.

Drugmakers should use diagrams where necessary, and flowcharts with top-to-bottom instructions can be especially helpful for global pharmaceutical companies with a culturally diverse staff, Sally Breisch, chief operations officer and medical writer at Amarex, said.

Sponsors and CROs are buried under the weight of wordy SOPs. Regain control of your SOP and register for FDAnews’ encour presentation of Your Clinical SOPs Are Too Long!
Reduce Wordy SOPs to Improve Compliance.

In 90-minutes, two of the industry’s best clinical SOP experts will teach you how to regain control of your SOP writing process, cut costs from duplicative writing activities and, most importantly, increase compliance. Don’t delay, register today.